rs1799782 — XRCC1 R194W

XRCC1 R194W — A DNA Repair Variant With a Split Personality

XRCC1 (X-Ray Repair Cross-Complementing group 1) is the master scaffold protein of base excision repair (BER)¹¹ base excision repair (BER)
the primary pathway for fixing small DNA lesions caused by oxidative stress, alkylation, and deamination — responsible for repairing tens of thousands of DNA lesions per cell per day. Rather than cutting or unwinding DNA itself, XRCC1 acts as a molecular coordinator — physically recruiting and organizing the enzymes that detect, excise, and patch damaged DNA bases. The R194W variant (rs1799782) changes arginine to tryptophan at position 194, right in the linker region between the N-terminal domain and the first BRCT domain²² linker region between the N-terminal domain and the first BRCT domain
XRCC1 has three functional domains: the N-terminal domain (NTD, interacting with DNA polymerase beta), BRCT1 (interacting with PARP1), and BRCT2 (interacting with DNA ligase III). Linker 1 connects NTD to BRCT1., and it produces one of the most complex pictures in cancer genetics — protective against some cancers, risky for others, and dramatically different across ancestral populations.

The Mechanism

The R194W substitution sits in linker 1 of XRCC1, a region now recognized as functionally critical rather than merely structural. Campalans et al. (2015)³³ Campalans et al. (2015)
Interaction with OGG1 is required for efficient recruitment of XRCC1 to base excision repair and maintenance of genetic stability after exposure to oxidative stress. Mol Cell Biol, 2015 demonstrated that the R194W variant specifically disrupts the interaction between XRCC1 and OGG1⁴⁴ OGG1
8-oxoguanine DNA glycosylase 1, the enzyme that initiates BER by recognizing and excising 8-oxoguanine, the most common oxidative DNA lesion. While the R194W protein can still perform single-strand break repair normally, it fails to colocalize with OGG1 at sites of oxidative base damage. When XRCC1-deficient cells were complemented with the R194W variant and exposed to oxidative stress, they accumulated micronuclei⁵⁵ micronuclei
small extra-nuclear bodies containing chromosome fragments, a direct marker of genomic instability — indicating that BER intermediates were left unresolved, leading to genetic instability.

This selective impairment is key: R194W does not cripple all XRCC1 functions equally. It specifically undermines the repair of oxidative base lesions (the OGG1-initiated pathway) while leaving single-strand break repair intact. This explains why the variant's cancer associations are complex and context-dependent rather than uniformly harmful.

The Evidence

Gastric cancer — increased risk. A meta-analysis of 18 studies⁶⁶ meta-analysis of 18 studies
Chen B et al. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep, 2012 encompassing 3,915 gastric cancer cases and 6,759 controls found that Trp/Trp homozygotes had significantly increased gastric cancer risk (OR 1.31, 95% CI 1.04-1.65), with the association strongest in Asian populations. Given that the stomach lining faces chronic oxidative stress from gastric acid production and Helicobacter pylori⁷⁷ Helicobacter pylori
a bacterium that colonizes the stomach lining and generates reactive oxygen species, causing chronic inflammation and DNA damage infection, impaired OGG1-mediated repair in gastric mucosa is a biologically plausible mechanism.

Lung cancer — population-dependent picture. In Caucasian populations, a meta-analysis by Chen et al.⁸⁸ meta-analysis by Chen et al.
XRCC1 polymorphisms and lung cancer risk in Caucasian populations: a meta-analysis. Int J Clin Exp Med, 2015 found no significant overall association (OR 0.94, 95% CI 0.73-1.21). In Chinese populations, Zheng et al. (2009)⁹⁹ Zheng et al. (2009)
XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer similarly found no association (OR 1.06, 95% CI 0.89-1.27) in a pooled analysis of 2,861 cases and 2,783 controls. The lung cancer picture thus appears largely null for R194W specifically, in contrast to the same gene's R399Q variant (rs25487) which shows clearer lung cancer associations.

Breast cancer — metastasis correlations. A study by Li et al. (2018)¹⁰¹⁰ study by Li et al. (2018)
XRCC1 rs1799782 (C194T) polymorphism correlated with tumor metastasis and molecular subtypes in breast cancer. Onco Targets Ther found that lymphatic metastasis was associated with higher frequency of the variant allele, and that the variant correlated with specific molecular subtypes (PR-positive, HER2-positive, ER-negative). This suggests the variant may influence tumor aggressiveness rather than cancer initiation per se.

Chemotherapy response — the silver lining. One of the most actionable findings is that R194W carriers respond better to platinum-based chemotherapy. Zhang et al. (2020)¹¹¹¹ Zhang et al. (2020)
Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC. Biomed Res Int analyzed 23 studies with 5,567 NSCLC patients and found a clear gene-dosage effect: Trp/Trp carriers had significantly better treatment response than Arg/Arg (OR 1.73, 95% CI 1.31-2.27), with heterozygotes intermediate (OR 1.28, 95% CI 1.06-1.55). Trp/Trp carriers also showed longer overall survival. The mechanism is straightforward: platinum drugs work by creating DNA crosslinks, and impaired BER means tumor cells are less able to repair this therapeutic damage.

Ancestry variation. The variant allele frequency varies dramatically by ancestry: approximately 30% in East Asian populations compared to just 6% in Europeans and Africans. This substantial frequency difference is important context — a variant this common in East Asian populations is unlikely to be uniformly deleterious, and may reflect balancing selection or genetic drift.

Practical Actions

The OGG1-specific repair defect means the variant's consequences are most pronounced under conditions of high oxidative stress. Supporting antioxidant defenses and minimizing oxidative DNA damage burden are the most direct interventions. Magnesium and zinc are specific cofactors for BER enzymes — XRCC1 requires zinc for structural integrity, and magnesium is essential for DNA polymerase beta activity during the gap-filling step of BER. Ensuring adequate levels of these minerals directly supports the repair pathway that R194W impairs.

For carriers who are ever diagnosed with cancer, the pharmacogenomic data on platinum chemotherapy response is directly relevant and should be communicated to the oncology team.

Interactions

XRCC1 R194W (rs1799782) and R399Q (rs25487) are in the same gene but affect different functional domains — R194W disrupts OGG1 interaction in linker 1, while R399Q affects the BRCT1 domain that binds PARP1. Individuals carrying variant alleles at both positions may have compounded BER impairment across two distinct arms of the pathway. Published studies examining compound heterozygosity at both positions have shown additive effects on cancer risk in some populations. The NBS1 E185Q variant (rs1805794) in the double-strand break repair pathway is also relevant — combined impairment of both BER and DSB repair creates a broader DNA repair deficit. The interaction between XRCC1 variants and smoking exposure is particularly important: tobacco smoke generates both oxidative base lesions (repaired via OGG1-XRCC1) and bulky adducts, and impaired BER amplifies the mutagenic consequences of each cigarette.